Cumberland Pharmaceuticals

(NASDAQ) CPIX

Current Price$4.32

Market Cap$65.21M

Since IPO (2009)-74%

5 Year+63%

1 Year-9%

1 Month+41%

Cumberland Pharmaceuticals Financials at a Glance

Market Cap

$65.21M

Revenue (TTM)

$44.52M

Net Income (TTM)

$2.84M

EPS (TTM)

$-0.19

P/E Ratio

-22.79

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$4.32

Volume

10,191

Open

$4.20

Price

$4.32

Volume

10,191

Open

$4.20

Previous Close

$4.32

Daily Range

$4.07 - $4.32

52-Week Range

$1.85 - $6.26

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$4.32

Volume

10,191

Open

$4.20

Previous Close

$4.32

Daily Range

$4.07 - $4.32

52-Week Range

$1.85 - $6.26

CPIX News

Cumberland (CPIX) Q2 Revenue Up 10%

Motley Fool Markets TeamAug 6, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cumberland Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

A. J. Kazimi, MBA

Website

www.cumberlandpharma.com

Headquarters

Nashville, TN 37203, US

CPIX Financials

Key Financial Metrics (TTM)

Gross Margin

85%

Operating Margin

-6%

Net Income Margin

-6%

Return on Equity

-12%

Return on Capital

-7%

Return on Assets

-4%

Earnings Yield

-4.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$65.21M

Shares Outstanding

14.96M

Volume

10.19K

Avg. Volume

986.56K

Financials (TTM)

Gross Profit

$37.85M

Operating Income

$2.79M

EBITDA

$2.49M

Operating Cash Flow

$4.93M

Capital Expenditure

$97.90K

Free Cash Flow

$4.83M

Cash & ST Invst.

$11.44M

Total Debt

$10.18M

Cumberland Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$13.68M

+31.1%

Gross Profit

$11.44M

+35.2%

Gross Margin

83.61%

N/A

Market Cap

$65.21M

N/A

Market Cap/Employee

$716.60K

N/A

Employees

N/A

Net Income

$1.41M

+25.8%

EBITDA

$47.84K

+3.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.26M

+148.5%

Accounts Receivable

$16.94M

+44.8%

Inventory

$6.23M

+55.6%

Long Term Debt

$9.71M

-35.7%

Short Term Debt

$467.77K

-91.4%

Return on Assets

-3.69%

N/A

Return on Invested Capital

-6.97%

N/A

Free Cash Flow

$3.03K

-99.8%

Operating Cash Flow

$3.02K

-99.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LVTXLAVA Therapeutics N.V.

LVTXLAVA Therapeutics N.V.$1.74-3.87%

RMTIRockwell Medical, Inc.

RMTIRockwell Medical, Inc.$0.89+1.29%

DYAIDyadic International, Inc.

DYAIDyadic International, Inc.$0.79+0.70%

LTRNLantern Pharma Inc.

LTRNLantern Pharma Inc.$2.12+3.41%

CELUCelularity Inc.

CELUCelularity Inc.$0.96+2.43%

QNTMQuantum BioPharma Ltd.

QNTMQuantum BioPharma Ltd.$5.55-3.14%

ABVCABVC BioPharma, Inc.

ABVCABVC BioPharma, Inc.$1.03+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About CPIX

What is the current price of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals is trading at $4.32 per share.

What is the 52-week range for Cumberland Pharmaceuticals?

Over the past 52 weeks, Cumberland Pharmaceuticals has traded between $1.85 and $6.27.

How much debt does Cumberland Pharmaceuticals have?

As of the most recent reporting period, Cumberland Pharmaceuticals reported total debt of $10.18M.

How much cash does Cumberland Pharmaceuticals have on hand?

Cumberland Pharmaceuticals reported $11.44M in cash and cash equivalents in its most recent financial results.

What is Cumberland Pharmaceuticals’s dividend yield?

Cumberland Pharmaceuticals does not currently have a dividend yield.

Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Financials at a Glance

CPIX News

Cumberland (CPIX) Q2 Revenue Up 10%

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cumberland Pharmaceuticals

CPIX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cumberland Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CPIX

What is the current price of Cumberland Pharmaceuticals?

What is the 52-week range for Cumberland Pharmaceuticals?

How much debt does Cumberland Pharmaceuticals have?

How much cash does Cumberland Pharmaceuticals have on hand?

What is Cumberland Pharmaceuticals’s dividend yield?

Premium Investing Services